These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22678371)

  • 21. Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.
    Mehta A; Beck M; Elliott P; Giugliani R; Linhart A; Sunder-Plassmann G; Schiffmann R; Barbey F; Ries M; Clarke JT;
    Lancet; 2009 Dec; 374(9706):1986-96. PubMed ID: 19959221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
    Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
    Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fabry's disease].
    Maire I; Belmatoug N
    Presse Med; 2007 Jan; 36(1 Pt 1):69-70. PubMed ID: 17261453
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fabry's disease in 2006: new treatment needs evaluation].
    Lidove O; Bekri S; Andrès E
    Presse Med; 2006 Jun; 35(6 Pt 1):933-5. PubMed ID: 16783249
    [No Abstract]   [Full Text] [Related]  

  • 25. Agalsidase beta (Fabrazyme) for Fabry disease.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):74-5. PubMed ID: 12968124
    [No Abstract]   [Full Text] [Related]  

  • 26. Fabry disease: clinical outcomes of agalsidase enzyme replacement therapies.
    Wanner C
    Int J Clin Pract; 2007 Jul; 61(7):1234-5; author reply 1235. PubMed ID: 17577304
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fabry disease: new clinical research--current therapeutic perspectives].
    Beck M
    Wien Klin Wochenschr; 2003 Apr; 115(7-8):215-7. PubMed ID: 12778772
    [No Abstract]   [Full Text] [Related]  

  • 28. Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.
    Mehta A; Beck M; Kampmann C; Frustaci A; Germain DP; Pastores GM; Sunder-Plassmann G
    Mol Genet Metab; 2008; 95(1-2):114-5. PubMed ID: 18701330
    [No Abstract]   [Full Text] [Related]  

  • 29. Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?
    Banikazemi M; Desnick RJ
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):72-3. PubMed ID: 16932395
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intravenous lidocaine as treatment for the painful episodes in Fabry's disease].
    Politei JM
    Rev Neurol; 2009 Aug 1-15; 49(3):166-7. PubMed ID: 19621314
    [No Abstract]   [Full Text] [Related]  

  • 31. Immune response to enzyme replacement therapy in Fabry disease: impact on clinical outcome?
    Hollak CE; Linthorst GE
    Mol Genet Metab; 2009 Jan; 96(1):1-3. PubMed ID: 19062323
    [No Abstract]   [Full Text] [Related]  

  • 32. Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease?
    Basic-Jukic N; Kes P; Mokos I; Coric M
    Med Hypotheses; 2009 Apr; 72(4):476-7. PubMed ID: 19124204
    [No Abstract]   [Full Text] [Related]  

  • 33. Nature's transplant in Fabry's disease.
    Beutler E
    Lancet; 1979 Jul; 2(8135):199. PubMed ID: 89308
    [No Abstract]   [Full Text] [Related]  

  • 34. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
    Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
    G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fabry's disease revealed by stroke: a case report].
    Ronzière T
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S260-2. PubMed ID: 21211676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme replacement in Fabry disease: the essence is in the kidney.
    Schiffmann R
    Ann Intern Med; 2007 Jan; 146(2):142-4. PubMed ID: 17179053
    [No Abstract]   [Full Text] [Related]  

  • 37. Enzyme replacement therapy and Fabry kidney disease: quo vadis?
    Warnock DG
    J Am Soc Nephrol; 2007 May; 18(5):1368-70. PubMed ID: 17429046
    [No Abstract]   [Full Text] [Related]  

  • 38. Fabry's disease and cerebrovascular disorders.
    Federico A
    Neurol Sci; 2002 Jun; 23(2):47-8. PubMed ID: 12296291
    [No Abstract]   [Full Text] [Related]  

  • 39. Agalsidase treatment for Fabry disease: uses and rivalries.
    Schiffmann R
    Genet Med; 2010 Nov; 12(11):684-5. PubMed ID: 20975568
    [No Abstract]   [Full Text] [Related]  

  • 40. March on, not in.
    Nat Med; 2011 May; 17(5):515. PubMed ID: 21546944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.